Glance on Wanbang Biopharma
The Oral Solid Dosage Form Production Line of Wanbang Biopharma Passed FDA Site Inspection
To improve the comprehensive management of chronic diseases, the public welfare project "NCD diagnosis and treatment training course" launched in Beijing
Zero Distance to Wanbang Biopharma
Focusing on the diabetes as the core therapeutic field,
Wanbang Biopharma has established a core competitive advantage in R&D, production and sales in the field of "Four High One Anti" (hyperglycemia, hypertension, hyperlipidemia, hyperuricemia and anti-tumor).